Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385325947> ?p ?o ?g. }
- W4385325947 abstract "ABSTRACT Introduction: This review aims to provide evidence-based recommendations for an enhanced primary series (third dose) coronavirus disease 2019 (COVID-19) vaccination in people with rheumatic diseases (PRDs) in the local and regional context. Methods: Literature reviews were performed regarding the necessity, efficacy, safety and strategies for enhanced primary series COVID-19 vaccination in PRDs. Recommendations were developed based on evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Evidence was synthesised by eight working group members, and the consensus was achieved by a Delphi method with nine members of an expert task force panel. Results: Two graded recommendations and one ungraded position statement were developed. PRDs have impaired immunogenicity from the COVID-19 vaccine and are at an increased risk of postvaccine breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and poor clinical outcomes, compared to the general population. We strongly recommend that PRDs on immunomodulatory drugs be offered a third dose of the messenger RNA (mRNA) vaccine as part of an enhanced primary series, after the standard two-dose regimen. We conditionally recommend that the third dose of mRNA vaccine against SARS-CoV-2 be given at least 4 weeks after the second dose or as soon as possible thereafter. There is insufficient data to inform whether the third mRNA vaccine should be homologous or heterologous in PRDs. Conclusion: These recommendations that were developed through evidence synthesis and formal consensus process provide guidance for an enhanced primary series COVID-19 vaccination in PRDs." @default.
- W4385325947 created "2023-07-28" @default.
- W4385325947 creator A5004507834 @default.
- W4385325947 creator A5006506953 @default.
- W4385325947 creator A5007132349 @default.
- W4385325947 creator A5011880497 @default.
- W4385325947 creator A5012905920 @default.
- W4385325947 creator A5023914917 @default.
- W4385325947 creator A5029972712 @default.
- W4385325947 creator A5031060060 @default.
- W4385325947 creator A5032533439 @default.
- W4385325947 creator A5040646736 @default.
- W4385325947 creator A5046769940 @default.
- W4385325947 creator A5057553094 @default.
- W4385325947 creator A5074157226 @default.
- W4385325947 creator A5074159599 @default.
- W4385325947 creator A5088224373 @default.
- W4385325947 creator A5088550144 @default.
- W4385325947 date "2023-07-27" @default.
- W4385325947 modified "2023-10-03" @default.
- W4385325947 title "Recommendations for enhanced primary series (third dose) COVID-19 vaccination for people with rheumatic diseases: Chapter of Rheumatologists, College of Physicians, Singapore" @default.
- W4385325947 cites W2111722073 @default.
- W4385325947 cites W2145881672 @default.
- W4385325947 cites W2165010366 @default.
- W4385325947 cites W3092151577 @default.
- W4385325947 cites W3102798166 @default.
- W4385325947 cites W3112956657 @default.
- W4385325947 cites W3124810175 @default.
- W4385325947 cites W3130465197 @default.
- W4385325947 cites W3139490202 @default.
- W4385325947 cites W3160026234 @default.
- W4385325947 cites W3162622073 @default.
- W4385325947 cites W3164060144 @default.
- W4385325947 cites W3164069651 @default.
- W4385325947 cites W3165023402 @default.
- W4385325947 cites W3165694484 @default.
- W4385325947 cites W3168511545 @default.
- W4385325947 cites W3170450599 @default.
- W4385325947 cites W3176062748 @default.
- W4385325947 cites W3176527986 @default.
- W4385325947 cites W3176897911 @default.
- W4385325947 cites W3179335016 @default.
- W4385325947 cites W3179592661 @default.
- W4385325947 cites W3183904285 @default.
- W4385325947 cites W3183906277 @default.
- W4385325947 cites W3187717873 @default.
- W4385325947 cites W3187850115 @default.
- W4385325947 cites W3188556989 @default.
- W4385325947 cites W3189930139 @default.
- W4385325947 cites W3190427561 @default.
- W4385325947 cites W3192715231 @default.
- W4385325947 cites W3193259004 @default.
- W4385325947 cites W3194809099 @default.
- W4385325947 cites W3195586393 @default.
- W4385325947 cites W3196332529 @default.
- W4385325947 cites W3196661325 @default.
- W4385325947 cites W3196706653 @default.
- W4385325947 cites W3201177512 @default.
- W4385325947 cites W3201408162 @default.
- W4385325947 cites W3202007017 @default.
- W4385325947 cites W3207290229 @default.
- W4385325947 cites W4205625239 @default.
- W4385325947 cites W4210264706 @default.
- W4385325947 cites W4213451248 @default.
- W4385325947 cites W4225678041 @default.
- W4385325947 cites W4225982774 @default.
- W4385325947 cites W4226320088 @default.
- W4385325947 doi "https://doi.org/10.4103/singaporemedj.smj-2022-070" @default.
- W4385325947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37530384" @default.
- W4385325947 hasPublicationYear "2023" @default.
- W4385325947 type Work @default.
- W4385325947 citedByCount "0" @default.
- W4385325947 crossrefType "journal-article" @default.
- W4385325947 hasAuthorship W4385325947A5004507834 @default.
- W4385325947 hasAuthorship W4385325947A5006506953 @default.
- W4385325947 hasAuthorship W4385325947A5007132349 @default.
- W4385325947 hasAuthorship W4385325947A5011880497 @default.
- W4385325947 hasAuthorship W4385325947A5012905920 @default.
- W4385325947 hasAuthorship W4385325947A5023914917 @default.
- W4385325947 hasAuthorship W4385325947A5029972712 @default.
- W4385325947 hasAuthorship W4385325947A5031060060 @default.
- W4385325947 hasAuthorship W4385325947A5032533439 @default.
- W4385325947 hasAuthorship W4385325947A5040646736 @default.
- W4385325947 hasAuthorship W4385325947A5046769940 @default.
- W4385325947 hasAuthorship W4385325947A5057553094 @default.
- W4385325947 hasAuthorship W4385325947A5074157226 @default.
- W4385325947 hasAuthorship W4385325947A5074159599 @default.
- W4385325947 hasAuthorship W4385325947A5088224373 @default.
- W4385325947 hasAuthorship W4385325947A5088550144 @default.
- W4385325947 hasBestOaLocation W43853259471 @default.
- W4385325947 hasConcept C126322002 @default.
- W4385325947 hasConcept C151730666 @default.
- W4385325947 hasConcept C203014093 @default.
- W4385325947 hasConcept C22070199 @default.
- W4385325947 hasConcept C2779343474 @default.
- W4385325947 hasConcept C2781413609 @default.
- W4385325947 hasConcept C2908647359 @default.
- W4385325947 hasConcept C512399662 @default.
- W4385325947 hasConcept C71924100 @default.
- W4385325947 hasConcept C86803240 @default.